Walgreens Boots Alliance, Inc. (WBA)
Largest Insider Buys in Sector
WBA Stock Price History Chart
WBA Stock Performance
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane …
Insider Activity of Walgreens Boots Alliance, Inc.
Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $512,643 and sold $371,017 worth of Walgreens Boots Alliance, Inc. stock.
On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $499,568 and sold $497,500 worth of stock each year.
Highest buying activity among insiders over the last 12 months: WENTWORTH TIMOTHY C (Chief Executive Officer) — $484,440. JARRETT VALERIE B (director) — $199,985. Mahajan Manmohan (EVP and Global CFO) — $116,280.
The last purchase of 3,000 shares for transaction amount of $54,150 was made by Bhandari Inderpal S (director) on 2024‑04‑11.
List of Insider Buy and Sell Transactions, Walgreens Boots Alliance, Inc.
| 2024-04-11 | director | 3,000 0.0003% | $18.05 | $54,150 | -35.73% | |||
| 2024-04-02 | EVP and Global CFO | 6,000 0.0007% | $19.38 | $116,280 | -36.70% | |||
| 2024-01-29 | director | 4,456 0.0005% | $22.44 | $99,993 | -28.90% | |||
| 2024-01-16 | Sale | director | 15,209 0.0018% | $23.05 | $350,567 | -26.06% | ||
| 2024-01-05 | Chief Executive Officer | 10,000 0.0011% | $24.22 | $242,220 | -30.31% | |||
| 2023-11-10 | Sale | SVP, Chief Pharmacy Officer | 1,000 0.0001% | $20.45 | $20,450 | -12.99% | ||
| 2023-06-30 | EVP, Pres. U.S. Healthcare | 5,172 0.0006% | $28.42 | $146,984 | -23.94% | |||
| 2023-03-29 | CEO | 10,000 0.0012% | $33.95 | $339,510 | -28.17% | |||
| 2022-11-18 | Sale | EVP, Chief Medical Officer | 10,303 0.0012% | $40.19 | $414,108 | -18.41% | ||
| 2022-11-17 | Sale | director | 16,570 0.0019% | $39.89 | $660,928 | -19.14% | ||
| 2021-11-19 | Sale | director | 2,725 0.0003% | $47.16 | $128,497 | -6.94% | ||
| 2020-11-11 | Sale | EVP, Global CAO and GC | 10,000 0.0012% | $41.55 | $415,450 | +21.52% | ||
| 2019-11-05 | Sale | EVP, Global CAO and GC | 468,710 0.0543% | $63.16 | $29.6M | -28.46% | ||
| 2019-08-15 | Sale | EVP, Global CAO and GC | 246,992 0.0272% | $50.06 | $12.36M | +3.23% | ||
| 2019-08-14 | Sale | EVP, Global CAO and GC | 183,654 0.0202% | $51.03 | $9.37M | +0.91% | ||
| 2019-05-09 | Sale | EVP, Global CAO and GC | 40,000 0.0044% | $53.05 | $2.12M | +0.56% | ||
| 2019-04-03 | Co-Chief Operating Officer | 36,000 0.0039% | $54.56 | $1.96M | -0.93% | |||
| 2018-11-20 | Sale | director | 14,100 0.0015% | $78.81 | $1.11M | -29.63% | ||
| 2018-11-01 | Sale | director | 5,472 0.0006% | $79.48 | $434,915 | -29.34% | ||
| 2018-11-01 | Sale | SVP, Global Controller and CAO | 15,705 0.0017% | $79.79 | $1.25M | -29.34% |
Insider Historical Profitability
| WENTWORTH TIMOTHY C | Chief Executive Officer | 585122 0.0677% | $9.30 | 1 | 0 | |
| Mahajan Manmohan | EVP and Global CFO | 166969 0.0193% | $9.30 | 1 | 0 | |
| JARRETT VALERIE B | director | 4456 0.0005% | $9.30 | 1 | 0 | |
| Bhandari Inderpal S | director | 3000 0.0003% | $9.30 | 1 | 0 | |
| Pessina Stefano | Executive Vice Chairman, CEO | 144788821 16.746% | $9.30 | 3 | 1 | +4.43% |
Institutional Investor Ownership
| The Vanguard Group | $1.78B | 9.53 | 82.26M | -1.06% | -$19.1M | 0.03 | |
| BlackRock | $1.48B | 7.89 | 68.13M | +3.4% | +$48.58M | 0.03 | |
| State Street | $785.04M | 4.19 | 36.19M | -33.2% | -$390.11M | 0.03 | |
| Capital World Investors | $630.33M | 3.37 | 29.06M | +57.52% | +$230.18M | 0.11 | |
| Geode Capital Management | $409.49M | 2.19 | 18.88M | +13.99% | +$50.25M | 0.04 |